Tag: Androgen receptor inhibitor breakthrough

Home / Androgen receptor inhibitor breakthrough

Categories

Enzalutamide is approved by the USFDA for non-metastatic castration-sensitive prostate cancer with biochemical recurrence

The FDA has authorized enzalutamide for the treatment of non-metastatic castration-sensitive prostate cancer in cases of biochemical recurrence.The Food and Drug Administration approved enzalutamide ...
androgen-receptor-inhibitor-breakthrough

Scan the code